Cardio Diagnostics Holdings, Inc. CDIO
1.65 USD -0.02 (-1.43%)
At closeNov 6, 2026, 4:00 PM EST
1.64 -0.01 -0.67%
After hours · Nov 6, 4:00 PM ET
1.60 Day range 1.71
0.97 52-week range 7.91
- YTD
- -39.08%
- 1 year
- -55.62%
- Market cap
- 4.89M
- Revenue (ttm)
- 39.14K
- EPS (ttm)
- -2.91
- Shares out
- 40.44M
- Forward P/E
- -4.12
- YTD return
- -39.08%
- 1-year return
- -55.62%
- Volume
- 18.81K
- Avg volume
- 35.81K
- Open
- 1.70
- Previous close
- 1.68
- Day's range
- 1.60 – 1.71
- 52-week range
- 0.97 – 7.91
- Beta
- 4.68
- Price target
- 2.00 (+21.1%)
- Earnings date
- Jul 1, 2024
5D -0.09 (-5.17%)
Key statistics
- Enterprise value
- 5.91M
- PEG ratio
- 0.00
- Price / sales
- 1064.26
- Price / book
- 7.15
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 356.20%
- Free cash flow
- -5.92M
- Total cash
- 1.31M
- Total debt
- 870.45K
- Return on equity
- -293.27%
- Short % of float
- 5.52%
- 50-day average
- 0.44336
- 200-day average
- 0.598455
Analyst view
Price target (mean) 2.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Jul 1, 2024
Expected Jul 1, 2024. Consensus EPS estimate -0.06.
Financials — quick view
CDIO Revenue — quarterly 3.59K
CDIO Net income — quarterly -1.73M
CDIO EPS — quarterly -0.59
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | -0.15 | -0.06 | +0.09 | +60.00% |
| Jul 1, 2024 | Mar 1, 2024 | -0.10 | — | — | — |
| Apr 1, 2024 | Dec 1, 2023 | -0.13 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 27, 2024 | Benchmark | reit | Speculative Buy | Speculative Buy |
| Jun 6, 2024 | Benchmark | main | Speculative Buy | Speculative Buy |
| Apr 19, 2024 | Benchmark | main | Speculative Buy | Speculative Buy |
| Jun 15, 2023 | Benchmark | reit | Speculative Buy | Speculative Buy |
| May 22, 2023 | Northland Capital Markets | init | — | Outperform |
| Apr 18, 2023 | Benchmark | reit | — | Speculative Buy |
About Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- cardiodiagnosticsinc.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on CDIO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BURTON PAUL FREDERICK | Director | Conversion of Exercise of derivative security | Mar 27, 2024 | 8,803 |
| DOGAN MEESHANTHINI | Chief Technology Officer | Purchase | Sep 5, 2024 | 197,310 |
| DOGAN TIMUR | Chief Technology Officer | Purchase | Sep 5, 2024 | 197,310 |
| INTRATER JAMES | Director | Conversion of Exercise of derivative security | Mar 27, 2024 | 71,596 |
| LAU STANLEY K | Director | Conversion of Exercise of derivative security | Mar 27, 2024 | 100,325 |
| LEVY ODED | Director | Conversion of Exercise of derivative security | Mar 27, 2024 | 71,596 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 2.64% | 1,067,062 | 1.10M | Sep 29, 2024 |
| Vanguard Group Inc | 0.57% | 232,139 | 239.10K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.46% | 184,409 | 189.94K | Sep 29, 2024 |
| Northern Trust Corporation | 0.12% | 48,619 | 50.08K | Sep 29, 2024 |
| State Street Corporation | 0.11% | 43,500 | 44.80K | Sep 29, 2024 |
| PNC Financial Services Group, Inc. | 0.10% | 40,500 | 41.71K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.57% | 232,139 | 239.10K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.29% | 116,769 | 120.27K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.07% | 27,496 | 28.32K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.05% | 20,997 | 21.63K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.03% | 11,944 | 12.30K | Oct 30, 2024 |